Trial · NCT02636868
Adverse events213
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 213
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia neonatal | Blood and lymphatic system disorders | Aerosolized Lucinactant (40 mg TPL/kg) | 22 | 70 | 26 |
| other | Anaemia neonatal | Blood and lymphatic system disorders | Aerosolized Lucinactant (80 mg TPL/kg) | 31 | 72 | 37 |
| other | Anaemia neonatal | Blood and lymphatic system disorders | nCPAP Only | 31 | 71 | 52 |
| other | Coagulation disorder neonatal | Blood and lymphatic system disorders | Aerosolized Lucinactant (40 mg TPL/kg) | 2 | 70 | 2 |
| other | Coagulation disorder neonatal | Blood and lymphatic system disorders | Aerosolized Lucinactant (80 mg TPL/kg) | 5 | 72 | 5 |
| other | Coagulation disorder neonatal | Blood and lymphatic system disorders | nCPAP Only | 1 | 71 | 1 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Aerosolized Lucinactant (40 mg TPL/kg) | 4 | 70 | 5 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Aerosolized Lucinactant (80 mg TPL/kg) | 6 | 72 | 6 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | nCPAP Only | 5 | 71 | 5 |
| other | Patent ductus arteriosus | Cardiac disorders | Aerosolized Lucinactant (40 mg TPL/kg) | 18 | 70 | 18 |
| other | Patent ductus arteriosus | Cardiac disorders | Aerosolized Lucinactant (80 mg TPL/kg) | 24 | 72 | 24 |
| other | Patent ductus arteriosus | Cardiac disorders | nCPAP Only | 24 | 71 | 26 |
| other | Tachycardia | Cardiac disorders | Aerosolized Lucinactant (40 mg TPL/kg) | 6 | 70 | 6 |
| other | Tachycardia | Cardiac disorders | Aerosolized Lucinactant (80 mg TPL/kg) | 6 | 72 | 9 |
| other | Tachycardia | Cardiac disorders | nCPAP Only | 2 | 71 | 2 |
| other | Atrial septal defect | Congenital, familial and genetic disorders | Aerosolized Lucinactant (40 mg TPL/kg) | 4 | 70 | 5 |
| other | Atrial septal defect | Congenital, familial and genetic disorders | Aerosolized Lucinactant (80 mg TPL/kg) | 4 | 72 | 4 |
| other | Atrial septal defect | Congenital, familial and genetic disorders | nCPAP Only | 2 | 71 | 2 |
| other | Abdominal distension | Gastrointestinal disorders | Aerosolized Lucinactant (40 mg TPL/kg) | 6 | 70 | 7 |
| other | Abdominal distension | Gastrointestinal disorders | Aerosolized Lucinactant (80 mg TPL/kg) | 5 | 72 | 8 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02636868/events